top of page
News Updates


What If a Message Could Lower Your Heart Risk? A New Trial Shows Digital Reminders Modestly Boost Statin Refills.
Digital Reminders

Medicine Decoded
Aug 311 min read


What if stopping your asthma inhaler in early pregnancy did more harm than good?
Case Review: 32-year-old G1P0 female at 8 weeks’ gestation presents for prenatal visit. History of moderate persistent asthma treated with budesonide inhaler twice daily and albuterol as needed. Vitals: BP 118/72 mm Hg, HR 78 bpm, SpO2 98% on room air. No recent exacerbations, no fever, non-smoker. Meds: budesonide inhaler, albuterol PRN. Pertinent negative: no missed doses reported and no oral steroid use in past year. Question: In this patient at 8 weeks' gestation who is w

Medicine Decoded
Aug 302 min read


What If Weight‑Loss Drugs Also Cut Heart Risk? Clear, practical takeaways from the science of GLP‑1 medications.
People hear a lot about new weight‑loss drugs in the news, and it can feel confusing: are these medicines just for shrinking your waistline, or do they change health risks we care about—like heart attacks? This post walks through what clinicians are studying and what that means for everyday people and students learning the topic. Evergreen topic: GLP‑1 receptor agonists and why they matter now. What this class of drugs does GLP‑1 receptor agonists are medicines that slow stom

Medicine Decoded
Aug 162 min read


Could a daily pill replace weekly weight‑loss shots? An evergreen take on oral GLP‑1 drugs and combo therapies
An evergreen take on oral GLP‑1 drugs and combo therapies

Medicine Decoded
Aug 131 min read


What If First‑in‑Human Trials Didn’t Take So Long? FDA says new actions can shave months off early drug development.
early drug development

Medicine Decoded
Aug 111 min read


When Every Minute Counts: Inside the Global Fight Against Sepsis
Inside the Global Fight Against Sepsis

Medicine Decoded
Aug 102 min read


What If You Knew When ALS Would Start? A New Study Says We're Getting Closer
Scientists Can Now Predict When ALS Symptoms Will Strike — Sometimes Years in Advance - according to a new study published in Nature Medicine on July 27, 2026

Medicine Decoded
Aug 12 min read


FDA Approves Zidesamtinib (Jideytro): A High-Yield Precision Oncology Case You Need to Know
FDA Approves Zidesamtinib (Jideytro): A High-Yield Precision Oncology Case

Medicine Decoded
Jul 283 min read
bottom of page



















